D.E. Shaw & Co’s Medicines Co MDCO Stock Holding History

D.E. Shaw & Co’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-60,000	Closed	-$5.1M	–	4475
2019 Q4	$5.1M	Buy	60,000 +30,000	+100%	+$2M	0.01%	1719
2019 Q3	$1.5M	Buy	+30,000	New	+$1.2M	﹤0.01%	2567
2019 Q2	–	Sell	-100,000	Closed	-$2.79M	–	3997
2019 Q1	$2.79M	Buy	+100,000	New	+$2.36M	﹤0.01%	1935
2017 Q4	–	Sell	-10,000	Closed	-$370K	–	3831
2017 Q3	$370K	Hold	10,000	–	–	﹤0.01%	3054
2017 Q2	$380K	Hold	10,000	–	–	﹤0.01%	2935
2017 Q1	$489K	Hold	10,000	–	–	﹤0.01%	2746
2016 Q4	$339K	Buy	+10,000	New	+$355K	﹤0.01%	3065

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

D.E. Shaw & Co's MDCO Position: Q1 2020 in Review

D.E. Shaw & Co sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 85,466 shares — an estimated $7.26M sold.

D.E. Shaw & Co first reported a position in MDCO in Q2 2013 and held it in 19 quarters. The position peaked at $35.6M in Q2 2014. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

D.E. Shaw & Co reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
D.E. Shaw & Co sold 85,466 Medicines Co shares in Q1 2020, an estimated $7.26M.
D.E. Shaw & Co first reported a position in Medicines Co in Q2 2013 and held it in 19 quarters.
D.E. Shaw & Co's Medicines Co position peaked at $35.6M in Q2 2014.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.